Hjem › Blodkreft › Maryland › Baltimore
Kliniske studier for Blodkreft i Baltimore, MD
18 studier for Blodkreft søker deltakere på steder i og rundt Baltimore (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
RekruttererFase 3
- MedStar Franklin Square Medical Center ( Site 0046), Baltimore
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- og 2 flere
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 23, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruttererObservasjonsstudie
- UM Saint Joseph Medical Center, Towson · 8 mi unna
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
RekruttererTidlig fase 1
- John Hopkins University, Baltimore
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
RekruttererFase 1
- Tania Jain, MD, Baltimore
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
RekruttererFase 2
- Johns Hopkins Hospital, Baltimore
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Johns Hopkins, Baltimore
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
RekruttererFase 2
- University of Maryland, Baltimore, Baltimore
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RekruttererObservasjonsstudie
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
RekruttererFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Johns Hopkins School of Medicine, Baltimore
Ocular Complications From Cancer Therapy - Patient Registry and Biobank
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Stoler Outpatient Cancer Center at the University of Maryland, Baltimore
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
RekruttererObservasjonsstudie
- University of Maryland Medical Center, Baltimore
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Johns Hopkins University, Baltimore
Blodkreft-studier i andre byer
- Houston, TX46 studier
- New York City, NY26 studier
- Boston, MA25 studier
- Washington, DC19 studier
- Seattle, WA18 studier
- Los Angeles, CA17 studier
- Durham, NC16 studier
- Chicago, IL15 studier
- Philadelphia, PA14 studier
- Atlanta, GA13 studier
- Nashville, TN13 studier
- Edison, NJ13 studier
Andre studier i Baltimore
- Ikke-småcellet lungekreft60 studier
- Brystkreft47 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Kreft (alle typer)37 studier
- Kolorektal kreft31 studier
- Pankreaskreft31 studier
- Metastatisk kreft28 studier
- Fedme25 studier
- Hjertesvikt24 studier
- Blærekreft24 studier
- Slag22 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.